MVP 2.22% 44.0¢ medical developments international limited

Financials, page-35

  1. 3,653 Posts.
    lightbulb Created with Sketch. 788
    I think you need to go back and read some previous financial reports to get some extra context about how this company reports.
    For example the results report from 25 August 2010 states:
    "highlights for the year included: ....Registrations achieved in 10 new countries, and being sought in a further 20"
    "The board of directors are pleased with the annual result and believe the company's strategies for delivering sustained long term growth in profitability are beginning to yield results."

    In the 7 years since that result, the following growth has actually been achieved:
    Revenue 8,296 to 18,904, 128% growth.
    NPAT 879 to 1,820, 107% growth.
    EPS 1.7 to 3.1 , 82% growth.
    Share price $0.2 to $5.11, 2455% increase
    Thus the growth in revenue has only been 12.5% per year for the last 7 years.
    Growth in NPAT and EPS has been lower.
    However the share price has rocketed.
    The company needs a huge increase in sales and profit to justify the current share price! How long will that take?
    Last edited by ZMan: 21/08/17
 
watchlist Created with Sketch. Add MVP (ASX) to my watchlist
(20min delay)
Last
44.0¢
Change
-0.010(2.22%)
Mkt cap ! $49.56M
Open High Low Value Volume
46.0¢ 46.0¢ 44.0¢ $61.85K 139.3K

Buyers (Bids)

No. Vol. Price($)
1 10442 44.0¢
 

Sellers (Offers)

Price($) Vol. No.
46.0¢ 313 2
View Market Depth
Last trade - 16.10pm 12/11/2024 (20 minute delay) ?
MVP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.